MICRORNAS AS BIOMARKERS IN THE DIFFERENTIATION OF HYPERTENSION CAUSED BY TAKAYASU ARTERITIS FROM ESSENTIAL HYPERTENSION

Huimin Ma,Delian Zhang
DOI: https://doi.org/10.1097/01.hjh.0001021156.66771.b8
IF: 4.9
2024-05-01
Journal of Hypertension
Abstract:Objective: We detected the expression of 10 pre-selected miRNAs in the plasma of patients Takayasu's arteritis(TA) and Essential Hypertension (EH) and explored whether miRNAs expression levels can be used as biomarkers to distinguish between TA and EH in the differential diagnosis. Design and method: The study included 20 TA patients and 20 EH patients. The plasma concentrations of miR-125a-5p, miR-126-3p, miR-146a-5p, miR-150-5p, miR-155-5p, miR-181a-5p, miR-203a-3p, miR-223-3p, miR-326 and miR-346 were measured by quantitative polymerase chain reaction. Role of plasma miRNAs concentration in the differential diagnosis of TA and EH was evaluated by the area under the receiver operating characteristic curve (ROC). Results: Compared with EH patients, the expression levels of miR-125a-5p, miR-155-5p, miR-181a-5p, miR-203a-3p, miR-326, and miR-346 in TA patients were lower (P < 0.05). After adjusting for potential confounding variables, including age, gender, systolic blood pressure, erythrocyte sedimentation rate, and renin, the differential expression of miR-155-5p, miR-181a-5p, and miR-203a-3p in TA and EH was still statistically significant (P < 0.05). ROC curve analysis showed that when the three microRNAs were combined, the sensitivity increased to 0.95, the specificity was 0.80, the area under the curve (AUC) was 0.805, and the 95% confidence interval (CI) [0.634 0.977]. Conclusions: The expression levels of miR-155-5p, miR-181a-5p and miR-203a-3p in TA patients were lower than those in EH patients. The combined diagnosis of the three microRNAs may be beneficial to the differentiation of hypertension caused by TA from EH.
peripheral vascular disease
What problem does this paper attempt to address?